PCMA: New OIG Report Cites Drug Manufacturer 'Copay Coupon' Use in Medicare Part D
September 19, 2014
September 19, 2014
WASHINGTON, Sept. 19 -- The Pharmaceutical Care Management Association issued the following news release:
"Copay coupons," a drug manufacturer marketing tactic often used to inflate sales of brand drugs among patients with prescription drug coverage, may now be infiltrating Medicare Part D, according to a new report (http://oig.hhs.gov/oei/reports/oei-05-12-00540.asp) from the Department of Health and Human Services Office of the Inspector General (OIG). Federal anti-kic . . .
"Copay coupons," a drug manufacturer marketing tactic often used to inflate sales of brand drugs among patients with prescription drug coverage, may now be infiltrating Medicare Part D, according to a new report (http://oig.hhs.gov/oei/reports/oei-05-12-00540.asp) from the Department of Health and Human Services Office of the Inspector General (OIG). Federal anti-kic . . .